Reimagining drug discovery using AI

We are laying the AI architecture for the future of personalized medicine. It enables data-driven decision making at each and every stage of drug discovery and development, and powers our internal discovery engine producing several novel promising drug candidates against cancer.

Our best-in-class foundational AI model of cellular communication serves as the most reliable digital twin of the human immune system in use-cases across drug discovery, patient stratification, and clinical trial simulation.

We DISCOVER&DERISK.